3-Benzoyloxy-11-oxo-12-ursen-28-oic acid



Compound IDCDAMM01283
Common name3-Benzoyloxy-11-oxo-12-ursen-28-oic acid
IUPAC name10-benzoyloxy-1,2,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,5,6,6a,7,8,8a,10,11,12,14b-tetradecahydropicene-4a-carboxylic acid
Molecular formulaC37H50O5

Experimental data

Retention time0.41
Adduct[M+Na]+
Actual mz597.36
Theoretical mz597.355
Error7.84
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3565

Identifiers and class information

Inchi keyRGCBYGZECVEZKC-UHFFFAOYNA-N
SmilesO=C(OC1CCC2(C)C3C(=O)C=C4C5C(C)C(C)CCC5(C(=O)O)CCC4(C)C3(C)CCC2C1(C)C)C=6C=CC=CC6
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)574.799
Computed dipole moment(dipole)5.004
Total solvent accessible surface area (SASA)834.537
Hydrophobic component of SASA (FOSA)521.781
Hydrophilic component of SASA (FISA)125.302
Pie component of the SASA (PISA)187.454
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1709.21
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)6
Free energy of solvation of dipole (dip^2/V)0.0146511
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0071896
Globularity descriptor (glob)0.828419
Predicted polarizability in cubic angstroms (QPpolrz)62.113
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.25
Predicted octanol/gas partition coefficient (QPlogPoct)25.999
Predicted water/gas partition coefficient (QPlogPw)10.568
Predicted octanol/water partition coefficient (QPlogPo/w)7.411
Predicted aqueous solubility (QPlogS)-8.719
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.994
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.395
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)162.652
Predicted brain/blood partition coefficient (QPlogBB)-0.835
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)88.359
Predicted skin permeability, log Kp (QPlogKp)-2.88
PM3 calculated ionization potential (IP(ev))9.98
PM3 calculated electron affinity (EA(eV))0.492
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)1.813
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)83.999
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)95.873
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction and SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SwissTargetPrediction and SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1

Copyright © 2025